OREANDA-NEWS. August 13, 2012. The Federal Antimonopoly Service (FAS Russia) found that Lipetsk Regional violated Part 3 Article 15 of the Federal Law “On Protection of Competition” and the Health Care Office of the Lipetsk Region violated Clauses 2, 3 Part 1 and Part 3 Article 15 of the Federal Law “On Protection of Competition”. Due to voluntary elimination of the exposed violations FAS terminated the case, reported the press-centre of FAS Russia. 

Lipetsk regional bodies confirmed to FAS that No.4 Order of the Head of the Lipetsk Regional Authority “On the Procedures for Drug Quality Control and Mandatory Certification in the Region” and No.74 Order of the Health Care Office of the Lipetsk Region “On the Measures for Preventing Entry of Rejected and Counterfeit Drugs to Pharmacies and Medical-and-Preventive Treatment Facilities in the Region” of 14th February 2003 were voluntarily abolished. The above Orders created conditions that forced wholesale drug sellers to undergo additional quality control of the drugs sold in the Lipetsk region.

FAS would like to remind that requirements or recommendations to pass additional “entry control” of the drugs the quality of which is confirmed by declarations (certificates) of conformance are unlawful.

Detailed information about “entry control” is available in the third issue of “Russian Competition Law and Economics” electronic research-to-practice journal.